Fifteen-minute consultation: Symptoms and signs of meningococcal disease

Michael Corr; Thomas Waterfield; Michael Shields

doi:10.1136/archdischild-2019-317722

Fifteen-minute consultation: Symptoms and signs of meningococcal disease

Michael Corr
, Thomas Waterfield
, Michael Shields

Research output: Contribution to journal › Review article › peer-review

6 Citations (Scopus)

527 Downloads (Pure)

Abstract

Meningococcal disease remains a leading cause of meningitis, sepsis and death in children worldwide and in the UK. Successful vaccination programmes in the UK have, however, significantly reduced the burden of disease in children. Unfortunately, despite vaccination, a significant number of children are still diagnosed with invasive meningococcal disease each year.As the prevalence of meningococcal disease falls, it is important that we maintain awareness of the symptoms and signs of meningococcal disease because the prompt recognition of this life-threatening infection improves outcomes.In this article we discuss the pathology, epidemiology and recognition of invasive meningococcal disease in children. The aim is to maintain awareness of this rare but life-threatening infection.

Original language	English
Journal	Archives of Disease in Childhood: Education and Practice Edition
Early online date	16 Oct 2019
DOIs	https://doi.org/10.1136/archdischild-2019-317722
Publication status	Early online date - 16 Oct 2019

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1136/archdischild-2019-317722Licence: Unspecified

Fifteen-minute consultation: Symptoms and signs of meningococcal disease
© 2019 Author(s) (or their employer(s)). No commercial re-use. This work is made available online in accordance with the publisher’s policies. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 208 KBLicence: Unspecified

Petechiae in Children (PiC) Study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA
Waterfield, T. (Author), Shields, M. (Supervisor), Fairley, D. (Supervisor) & Lynn, F. (Supervisor), Jul 2020
Student thesis: Doctoral Thesis › Doctor of Philosophy

File

Cite this

@article{378c61b4738e4c6898782e0bf978eecc,

title = "Fifteen-minute consultation: Symptoms and signs of meningococcal disease",

abstract = "Meningococcal disease remains a leading cause of meningitis, sepsis and death in children worldwide and in the UK. Successful vaccination programmes in the UK have, however, significantly reduced the burden of disease in children. Unfortunately, despite vaccination, a significant number of children are still diagnosed with invasive meningococcal disease each year.As the prevalence of meningococcal disease falls, it is important that we maintain awareness of the symptoms and signs of meningococcal disease because the prompt recognition of this life-threatening infection improves outcomes.In this article we discuss the pathology, epidemiology and recognition of invasive meningococcal disease in children. The aim is to maintain awareness of this rare but life-threatening infection.",

author = "Michael Corr and Thomas Waterfield and Michael Shields",

note = "{\textcopyright} Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.",

year = "2019",

month = oct,

day = "16",

doi = "10.1136/archdischild-2019-317722",

language = "English",

journal = "Archives of Disease in Childhood: Education and Practice Edition",

issn = "1743-0585",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Fifteen-minute consultation: Symptoms and signs of meningococcal disease

AU - Corr, Michael

AU - Waterfield, Thomas

AU - Shields, Michael

PY - 2019/10/16

Y1 - 2019/10/16

N2 - Meningococcal disease remains a leading cause of meningitis, sepsis and death in children worldwide and in the UK. Successful vaccination programmes in the UK have, however, significantly reduced the burden of disease in children. Unfortunately, despite vaccination, a significant number of children are still diagnosed with invasive meningococcal disease each year.As the prevalence of meningococcal disease falls, it is important that we maintain awareness of the symptoms and signs of meningococcal disease because the prompt recognition of this life-threatening infection improves outcomes.In this article we discuss the pathology, epidemiology and recognition of invasive meningococcal disease in children. The aim is to maintain awareness of this rare but life-threatening infection.

AB - Meningococcal disease remains a leading cause of meningitis, sepsis and death in children worldwide and in the UK. Successful vaccination programmes in the UK have, however, significantly reduced the burden of disease in children. Unfortunately, despite vaccination, a significant number of children are still diagnosed with invasive meningococcal disease each year.As the prevalence of meningococcal disease falls, it is important that we maintain awareness of the symptoms and signs of meningococcal disease because the prompt recognition of this life-threatening infection improves outcomes.In this article we discuss the pathology, epidemiology and recognition of invasive meningococcal disease in children. The aim is to maintain awareness of this rare but life-threatening infection.

U2 - 10.1136/archdischild-2019-317722

DO - 10.1136/archdischild-2019-317722

M3 - Review article

C2 - 31619453

SN - 1743-0585

JO - Archives of Disease in Childhood: Education and Practice Edition

JF - Archives of Disease in Childhood: Education and Practice Edition

ER -

Fifteen-minute consultation: Symptoms and signs of meningococcal disease

Abstract

Bibliographical note

UN SDGs

Access to Document

Fingerprint

Student theses

Petechiae in Children (PiC) Study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA

Cite this